What is Chelation Therapy?

Chelation therapy is a process in which an amino acid EDTA (ethylenediaminetetraacetic acid) is introduced into the bloodstream to remove heavy metals and/or minerals from the body. The literal meaning of Chelation is "to bind." When EDTA is delivered to the body, it binds metals such as lead, mercury, copper, iron, arsenic, aluminum, and calcium and removes them from the body via the kidneys. Since EDTA can be bound to calcium, one of the applications of chelation therapy is to reduce the calcification of atherosclerosis or narrowing of the arteries.

The benefits of EDTA chelation for cardiovascular disease lie not only in the removal of triggering factors, such as the free radicals generated by lead, but also in other ingredients of the intravenous treatment such as Vitamin C, B vitamins, and magnesium which help to improve the elasticity of arterial walls, circulation, and reduce inflammation.

EDTA chelation therapy is a series of intravenous treatments. After comprehensive assessment of the patient (including health history, physical examination and laboratory investigation), an individual treatment program is recommended. Throughout the treatments serum creatinine (kidney function) is monitored as well as urine metal excretion.

Intravenous EDTA is slowly administered as a drip for 2.5 to 3 hrs. Chelation of heavy metals can be done with CaEDTA and the duration of the treatment is 30 min. Patients with advanced disease usually require a course of 30-40 treatment sessions over a period of several months. Many patients notice differences in their symptoms and wellbeing half way through the course of treatment. As part of a comprehensive program for cardiovascular health and anti-aging, chelation is often combined with other IV treatments such as ozone, vitamin boosts, glutathione and phosphatidylcholine. Ask your physician about the right combination for your particular health concerns.

IV  Chelation Challenge Test
Heavy Metal Assesment


Low level exposure to heavy metals such as mercury, lead, cadmium, arsenic, aluminum, etc. can result in significant retention of these metals in the body. This can be associated with a wide variety of adverse health effects. Our body does not have ability to release these metals since they seem to be bound to the tissues. For an individual, toxicity occurs when the net retention exceeds the physiological tolerance.

In order to assess heavy metal load as part of our pre-chelation evaluation, we use the Urinary Heavy Metal Challenge Test. Three chelating agents are delivered via intravenous and oral routes and then a 24 hour urine collection determines the levels of heavy metals excreted and chelated from the body. After this evaluation, a recommendation is made regarding treatment for reducing this burden on the body through IV chelation treatments.